Inhibitory Antibodies
-
F1120 Anti-CALCA/CGRP Antibody (Fremanezumab)Summary: Anti-CALCA/CGRP Antibody (Fremanezumab) -
F1121 Anti-Sortilin/SORT1 Antibody (Latozinemab)Summary: Anti-Sortilin/SORT1 Antibody (Latozinemab) -
F1122 Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab)Summary: Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab) -
F1123 Anti-CX3CL1/Fractalkine Antibody (Quetmolimab)Summary: Anti-CX3CL1/Fractalkine Antibody (Quetmolimab) -
F1124 Anti-ROR2 Antibody (Ozuriftamab vedotin)Summary: Anti-ROR2 Antibody (Ozuriftamab vedotin) -
F1125 Anti-CD79b Antibody (Iladatuzumab vedotin)Summary: Anti-CD79b Antibody (Iladatuzumab vedotin) -
F1126 Anti-CD79b Antibody (Polatuzumab vedotin-piiq)Summary: Anti-CD79b Antibody (Polatuzumab vedotin-piiq) -
F1127 Anti-ALCAM/CD166 Antibody (Praluzatamab ravtansine)Summary: Anti-ALCAM/CD166 Antibody (Praluzatamab ravtansine) -
F1128 Anti-NCAM1/CD56 Antibody (Lorvotuzumab mertansine)Summary: Anti-NCAM1/CD56 Antibody (Lorvotuzumab mertansine) -
F1129 Anti-Siglec-2/CD22 Antibody (Pinatuzumab vedotin)Summary: Anti-Siglec-2/CD22 Antibody (Pinatuzumab vedotin)